Paula Mañaná
About Paula Mañaná
Paula Mañaná is a BCF and Finance Analyst at Bristol-Myers Squibb with over 9 years of experience at the company, previously serving as a Systems Coordinator.
Title and Current Role
Paula Mañaná currently holds the position of BCF and Finance Analyst at Bristol-Myers Squibb. In her role, she is responsible for business control functions and financial analysis within the organization. Her expertise in financial management is critical to maintaining the operational efficiency and fiscal health of the company.
Professional Experience at Bristol-Myers Squibb
Paula Mañaná has been employed at Bristol-Myers Squibb for over nine years, beginning her tenure as a Systems Coordinator from 2012 to 2014. She then transitioned to her current role as a BCF and Finance Analyst. She leverages her comprehensive understanding of the pharmaceutical industry and extensive experience in financial analysis to contribute effectively to the organization's goals.
Educational Background
Paula Mañaná completed her Master of Business Administration from the Inter American University School of Law, studying from 2009 to 2012. Prior to that, she earned her Bachelor's degree from the University of Puerto Rico, Río Piedras, between 2003 and 2008. Her educational background amalgamates business administration with law, providing a robust foundation for her career in finance and industry.
Transition from Systems Coordinator to BCF and Finance Analyst
Starting as a Systems Coordinator at Bristol-Myers Squibb, Paula Mañaná accumulated a wealth of experience over two years in this role from 2012 to 2014. Her responsibilities likely included managing and optimizing system operations that support business processes. She then stepped into the role of BCF and Finance Analyst by building on her previous experience and expanding her skill set in financial management and analysis.
Combining Legal and Financial Expertise
Paula Mañaná's diverse educational background in both law and business administration enables her to integrate legal principles with financial expertise. This unique combination allows her to navigate complex financial landscapes with a comprehensive understanding of legal frameworks, enhancing her analytical and problem-solving capabilities in her current role at Bristol-Myers Squibb.